DE69232791T2 - Carbapenemderivate - Google Patents
CarbapenemderivateInfo
- Publication number
- DE69232791T2 DE69232791T2 DE69232791T DE69232791T DE69232791T2 DE 69232791 T2 DE69232791 T2 DE 69232791T2 DE 69232791 T DE69232791 T DE 69232791T DE 69232791 T DE69232791 T DE 69232791T DE 69232791 T2 DE69232791 T2 DE 69232791T2
- Authority
- DE
- Germany
- Prior art keywords
- group
- alkyl group
- compound
- hydrogen atom
- nitrobenzyloxycarbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 claims abstract description 24
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 21
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 16
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 10
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims abstract description 6
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims description 114
- -1 methoxyethyl Chemical group 0.000 claims description 56
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 39
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 29
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 20
- 125000006239 protecting group Chemical group 0.000 claims description 18
- 125000004432 carbon atom Chemical group C* 0.000 claims description 14
- 125000005843 halogen group Chemical group 0.000 claims description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 claims description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 125000005633 phthalidyl group Chemical group 0.000 claims description 4
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 claims description 3
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 3
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 3
- 125000004434 sulfur atom Chemical group 0.000 claims description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 abstract description 33
- 239000001257 hydrogen Substances 0.000 abstract description 9
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 9
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 6
- 241000589517 Pseudomonas aeruginosa Species 0.000 abstract description 4
- 239000003242 anti bacterial agent Substances 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 abstract description 3
- 108090000790 Enzymes Proteins 0.000 abstract description 3
- 102000004157 Hydrolases Human genes 0.000 abstract description 3
- 108090000604 Hydrolases Proteins 0.000 abstract description 3
- WKDDRNSBRWANNC-ATRFCDNQSA-N Thienamycin Chemical compound C1C(SCCN)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 WKDDRNSBRWANNC-ATRFCDNQSA-N 0.000 abstract description 3
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 abstract description 3
- 230000003115 biocidal effect Effects 0.000 abstract description 3
- YKMONJZIUAOVEM-WDSKDSINSA-N 1beta-methylcarbapenem Chemical class C[C@H]1C=CN2C(=O)C[C@@H]12 YKMONJZIUAOVEM-WDSKDSINSA-N 0.000 abstract description 2
- 230000002411 adverse Effects 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 231100000417 nephrotoxicity Toxicity 0.000 abstract description 2
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 230000003389 potentiating effect Effects 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 206010029155 Nephropathy toxic Diseases 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000007694 nephrotoxicity Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 83
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 74
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 72
- 230000002829 reductive effect Effects 0.000 description 62
- 239000002904 solvent Substances 0.000 description 62
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 60
- 238000006243 chemical reaction Methods 0.000 description 59
- 238000005481 NMR spectroscopy Methods 0.000 description 51
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 50
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 48
- 239000000203 mixture Substances 0.000 description 47
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 40
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 36
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 34
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- 229910052938 sodium sulfate Inorganic materials 0.000 description 33
- 235000011152 sodium sulphate Nutrition 0.000 description 33
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 30
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 30
- 238000010898 silica gel chromatography Methods 0.000 description 30
- 238000001816 cooling Methods 0.000 description 29
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 24
- 238000001704 evaporation Methods 0.000 description 24
- 230000008020 evaporation Effects 0.000 description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 21
- 238000001914 filtration Methods 0.000 description 19
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- BSIMZHVOQZIAOY-SCSAIBSYSA-N 1-carbapenem-3-carboxylic acid Chemical group OC(=O)C1=CC[C@@H]2CC(=O)N12 BSIMZHVOQZIAOY-SCSAIBSYSA-N 0.000 description 17
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 17
- 235000017557 sodium bicarbonate Nutrition 0.000 description 17
- 229960004106 citric acid Drugs 0.000 description 16
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 15
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 238000003756 stirring Methods 0.000 description 14
- 101100422771 Caenorhabditis elegans sup-9 gene Proteins 0.000 description 13
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 13
- 125000001424 substituent group Chemical group 0.000 description 13
- 229940086542 triethylamine Drugs 0.000 description 13
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 12
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 12
- 239000012044 organic layer Substances 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000004440 column chromatography Methods 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- 229910052799 carbon Inorganic materials 0.000 description 8
- 239000003054 catalyst Substances 0.000 description 8
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 8
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 8
- 239000008363 phosphate buffer Substances 0.000 description 8
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
- BHIIGRBMZRSDRI-UHFFFAOYSA-N [chloro(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(Cl)OC1=CC=CC=C1 BHIIGRBMZRSDRI-UHFFFAOYSA-N 0.000 description 7
- 229910052786 argon Inorganic materials 0.000 description 7
- 150000001721 carbon Chemical group 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 7
- 229910003446 platinum oxide Inorganic materials 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- MHSGOABISYIYKP-UHFFFAOYSA-N (4-nitrophenyl)methyl carbonochloridate Chemical compound [O-][N+](=O)C1=CC=C(COC(Cl)=O)C=C1 MHSGOABISYIYKP-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- UOHJEDBIRDIRSB-UHFFFAOYSA-N (4-methoxyphenyl)methyl piperazine-1-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)N1CCNCC1 UOHJEDBIRDIRSB-UHFFFAOYSA-N 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 5
- 238000010531 catalytic reduction reaction Methods 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 238000005984 hydrogenation reaction Methods 0.000 description 5
- 239000002198 insoluble material Substances 0.000 description 5
- 239000011343 solid material Substances 0.000 description 5
- 239000002132 β-lactam antibiotic Substances 0.000 description 5
- 229940124586 β-lactam antibiotics Drugs 0.000 description 5
- XEZKLVYMADZCFU-SFTDATJTSA-N (4-nitrophenyl)methyl (2s,4s)-4-benzoylsulfanyl-2-(piperazine-1-carbonyl)pyrrolidine-1-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)N1[C@H](C(=O)N2CCNCC2)C[C@H](SC(=O)C=2C=CC=CC=2)C1 XEZKLVYMADZCFU-SFTDATJTSA-N 0.000 description 4
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical group O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 229920001281 polyalkylene Polymers 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- VXSXAAALVLUDAV-IRXDYDNUSA-N (2s,4s)-4-benzoylsulfanyl-1-[(4-nitrophenyl)methoxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound C([C@H](C[C@H]1C(=O)O)SC(=O)C=2C=CC=CC=2)N1C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 VXSXAAALVLUDAV-IRXDYDNUSA-N 0.000 description 3
- YKJCLNYKRUDGQA-GGAORHGYSA-N (4-methoxyphenyl)methyl 4-[(2s,4r)-4-hydroxy-1-[(4-nitrophenyl)methoxycarbonyl]pyrrolidine-2-carbonyl]piperazine-1-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)N1CCN(C(=O)[C@H]2N(C[C@H](O)C2)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 YKJCLNYKRUDGQA-GGAORHGYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- UIJGNTRUPZPVNG-UHFFFAOYSA-N benzenecarbothioic s-acid Chemical compound SC(=O)C1=CC=CC=C1 UIJGNTRUPZPVNG-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 150000002148 esters Chemical group 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 2
- AVUYDXAPBJERDH-JTQLQIEISA-N (2s)-2-hydroxy-4-[(4-nitrophenyl)methoxycarbonylamino]butanoic acid Chemical compound OC(=O)[C@@H](O)CCNC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 AVUYDXAPBJERDH-JTQLQIEISA-N 0.000 description 2
- JMJMJDNHVXYAOC-MNOVXSKESA-N (2s,4r)-4-hydroxy-1-[(4-nitrophenyl)methoxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound C1[C@H](O)C[C@@H](C(O)=O)N1C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 JMJMJDNHVXYAOC-MNOVXSKESA-N 0.000 description 2
- MDVDXPLKDZPQQB-VMPREFPWSA-N (4-methoxyphenyl)methyl 4-[(2s,4s)-4-benzoylsulfanyl-1-[(4-nitrophenyl)methoxycarbonyl]pyrrolidine-2-carbonyl]piperazine-1-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)N1CCN(C(=O)[C@H]2N(C[C@H](C2)SC(=O)C=2C=CC=CC=2)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 MDVDXPLKDZPQQB-VMPREFPWSA-N 0.000 description 2
- NSTLOENCEWRMIL-GDLZYMKVSA-N (4-methoxyphenyl)methyl 4-[2-[(2s)-3-[(4-nitrophenyl)methoxy]-2-[(4-nitrophenyl)methoxycarbonylamino]-3-oxopropyl]sulfanylacetyl]piperazine-1-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)N1CCN(C(=O)CSC[C@@H](NC(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 NSTLOENCEWRMIL-GDLZYMKVSA-N 0.000 description 2
- BOBQRMOOSVBPAV-UHFFFAOYSA-N (4-methoxyphenyl)methyl 4-[2-[(4-nitrophenyl)methoxycarbonylamino]acetyl]piperazine-1-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)N1CCN(C(=O)CNC(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 BOBQRMOOSVBPAV-UHFFFAOYSA-N 0.000 description 2
- MIAYNDCENHIBMX-XMMPIXPASA-N (4-nitrophenyl)methyl (2s)-3-[(4-methoxyphenyl)methylsulfanyl]-2-[(4-nitrophenyl)methoxycarbonylamino]propanoate Chemical compound C1=CC(OC)=CC=C1CSC[C@H](C(=O)OCC=1C=CC(=CC=1)[N+]([O-])=O)NC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 MIAYNDCENHIBMX-XMMPIXPASA-N 0.000 description 2
- FITQJGZFYCCXBY-QAXCHELISA-N (4-nitrophenyl)methyl (2s,4s)-2-[4-[2-[(2s)-3-[(4-nitrophenyl)methoxy]-2-[(4-nitrophenyl)methoxycarbonylamino]-3-oxopropyl]sulfanylacetyl]piperazine-1-carbonyl]-4-sulfanylpyrrolidine-1-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)N[C@@H](C(=O)OCC=1C=CC(=CC=1)[N+]([O-])=O)CSCC(=O)N1CCN(C(=O)[C@H]2N(C[C@@H](S)C2)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 FITQJGZFYCCXBY-QAXCHELISA-N 0.000 description 2
- SCOBBRKECDNGEH-UHULTCERSA-N (4-nitrophenyl)methyl (2s,4s)-4-[(4-methoxyphenyl)methylsulfanyl]-2-[4-[2-[(2s)-3-[(4-nitrophenyl)methoxy]-2-[(4-nitrophenyl)methoxycarbonylamino]-3-oxopropyl]sulfanylacetyl]piperazine-1-carbonyl]pyrrolidine-1-carboxylate Chemical compound C1=CC(OC)=CC=C1CS[C@@H]1CN(C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)[C@H](C(=O)N2CCN(CC2)C(=O)CSC[C@@H](NC(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)C1 SCOBBRKECDNGEH-UHULTCERSA-N 0.000 description 2
- NYCFDVXDKBLPNL-CHQNGUEUSA-N (4-nitrophenyl)methyl (2s,4s)-4-benzoylsulfanyl-2-[4-[(2s)-2-hydroxy-4-[(4-nitrophenyl)methoxycarbonylamino]butanoyl]piperazine-1-carbonyl]pyrrolidine-1-carboxylate Chemical compound C([C@H](O)C(=O)N1CCN(CC1)C(=O)[C@H]1N(C[C@H](C1)SC(=O)C=1C=CC=CC=1)C(=O)OCC=1C=CC(=CC=1)[N+]([O-])=O)CNC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 NYCFDVXDKBLPNL-CHQNGUEUSA-N 0.000 description 2
- OLMXVPSVDFERFC-CONSDPRKSA-N (4-nitrophenyl)methyl (2s,4s)-4-benzoylsulfanyl-2-[4-[2-[2-[(4-nitrophenyl)methoxycarbonylamino]ethoxy]acetyl]piperazine-1-carbonyl]pyrrolidine-1-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)NCCOCC(=O)N1CCN(C(=O)[C@H]2N(C[C@H](C2)SC(=O)C=2C=CC=CC=2)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 OLMXVPSVDFERFC-CONSDPRKSA-N 0.000 description 2
- HFFRDFCPYPRJLD-CONSDPRKSA-N (4-nitrophenyl)methyl (2s,4s)-4-benzoylsulfanyl-2-[4-[4-[(4-nitrophenyl)methoxycarbonylamino]butanoyl]piperazine-1-carbonyl]pyrrolidine-1-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)NCCCC(=O)N1CCN(C(=O)[C@H]2N(C[C@H](C2)SC(=O)C=2C=CC=CC=2)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 HFFRDFCPYPRJLD-CONSDPRKSA-N 0.000 description 2
- YMGVSGIDZRIHAX-UHFFFAOYSA-N (4-nitrophenyl)methyl n-(2-oxo-2-piperazin-1-ylethyl)carbamate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)NCC(=O)N1CCNCC1 YMGVSGIDZRIHAX-UHFFFAOYSA-N 0.000 description 2
- BUWNXCSLXNKFMX-AWEZNQCLSA-N (4-nitrophenyl)methyl n-[(3s)-3-hydroxy-4-oxo-4-piperazin-1-ylbutyl]carbamate Chemical compound C([C@H](O)C(=O)N1CCNCC1)CNC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 BUWNXCSLXNKFMX-AWEZNQCLSA-N 0.000 description 2
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 2
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 2
- PMYZPSRBBJLSTC-ZBFHGGJFSA-N 1-o-tert-butyl 2-o-ethyl (2s,4r)-4-(4-methylphenyl)sulfonyloxypyrrolidine-1,2-dicarboxylate Chemical compound C1N(C(=O)OC(C)(C)C)[C@H](C(=O)OCC)C[C@H]1OS(=O)(=O)C1=CC=C(C)C=C1 PMYZPSRBBJLSTC-ZBFHGGJFSA-N 0.000 description 2
- MWFLUYFYHANMCM-UHFFFAOYSA-N 2-(2-hydroxyethyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCO)C(=O)C2=C1 MWFLUYFYHANMCM-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NAXQWFOQWXJHMQ-UHFFFAOYSA-N 2-[2-[(4-nitrophenyl)methoxycarbonylamino]ethoxy]acetic acid Chemical compound OC(=O)COCCNC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 NAXQWFOQWXJHMQ-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- GNRLUBOJIGSVNT-UHFFFAOYSA-N Aminoethoxyacetic acid Chemical compound NCCOCC(O)=O GNRLUBOJIGSVNT-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229930186147 Cephalosporin Natural products 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000000010 aprotic solvent Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- 150000001780 cephalosporins Chemical class 0.000 description 2
- 239000007806 chemical reaction intermediate Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- VILAVOFMIJHSJA-UHFFFAOYSA-N dicarbon monoxide Chemical compound [C]=C=O VILAVOFMIJHSJA-UHFFFAOYSA-N 0.000 description 2
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 150000002960 penicillins Chemical class 0.000 description 2
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 125000004149 thio group Chemical group *S* 0.000 description 2
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 2
- IEYIODPJRHRCFY-KRWDZBQOSA-N (2r)-3-[(4-methoxyphenyl)methylsulfanyl]-2-[(4-nitrophenyl)methoxycarbonylamino]propanoic acid Chemical compound C1=CC(OC)=CC=C1CSC[C@@H](C(O)=O)NC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 IEYIODPJRHRCFY-KRWDZBQOSA-N 0.000 description 1
- IFQSXNOEEPCSLW-HSHFZTNMSA-N (2s)-2-amino-3-sulfanylpropanoic acid;hydron;chloride Chemical compound Cl.SC[C@@H](N)C(O)=O IFQSXNOEEPCSLW-HSHFZTNMSA-N 0.000 description 1
- PQPZSPJVMUCVAQ-SNVBAGLBSA-N (2s)-2-azaniumyl-3-[(4-methoxyphenyl)methylsulfanyl]propanoate Chemical compound COC1=CC=C(CSC[C@@H](N)C(O)=O)C=C1 PQPZSPJVMUCVAQ-SNVBAGLBSA-N 0.000 description 1
- IVUOMFWNDGNLBJ-VKHMYHEASA-N (2s)-4-amino-2-hydroxybutanoic acid Chemical compound NCC[C@H](O)C(O)=O IVUOMFWNDGNLBJ-VKHMYHEASA-N 0.000 description 1
- JQWUEVPNOSPHNN-OALUTQOASA-N (2s,4s)-4-[(4-methoxyphenyl)methylsulfanyl]-1-[(4-nitrophenyl)methoxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound C1=CC(OC)=CC=C1CS[C@@H]1CN(C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)[C@H](C(O)=O)C1 JQWUEVPNOSPHNN-OALUTQOASA-N 0.000 description 1
- NTKXLCUKUCGPRI-UHFFFAOYSA-N (4-methoxyphenyl)methyl 4-(2-chloroacetyl)piperazine-1-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)N1CCN(C(=O)CCl)CC1 NTKXLCUKUCGPRI-UHFFFAOYSA-N 0.000 description 1
- GKHBEBVUACVBBO-QFIPXVFZSA-N (4-methoxyphenyl)methyl 4-[(2s)-2-hydroxy-4-[(4-nitrophenyl)methoxycarbonylamino]butanoyl]piperazine-1-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)N1CCN(C(=O)[C@@H](O)CCNC(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 GKHBEBVUACVBBO-QFIPXVFZSA-N 0.000 description 1
- LGCGSFWLAZBSKM-UHFFFAOYSA-N (4-methoxyphenyl)methyl 4-[4-[(4-nitrophenyl)methoxycarbonylamino]butanoyl]piperazine-1-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)N1CCN(C(=O)CCCNC(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 LGCGSFWLAZBSKM-UHFFFAOYSA-N 0.000 description 1
- XTNCWEAGWCVIHH-MRXNPFEDSA-N (4-nitrophenyl)methyl (2s)-2-[(4-nitrophenyl)methoxycarbonylamino]-3-sulfanylpropanoate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)N[C@H](CS)C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 XTNCWEAGWCVIHH-MRXNPFEDSA-N 0.000 description 1
- OOXAOAURSROTJY-ROUUACIJSA-N (4-nitrophenyl)methyl (2s,4s)-2-[4-[2-(dimethylamino)acetyl]piperazine-1-carbonyl]-4-sulfanylpyrrolidine-1-carboxylate Chemical compound C1CN(C(=O)CN(C)C)CCN1C(=O)[C@H]1N(C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)C[C@@H](S)C1 OOXAOAURSROTJY-ROUUACIJSA-N 0.000 description 1
- HBTOGPHAEUNAJP-GOTSBHOMSA-N (4-nitrophenyl)methyl (2s,4s)-2-[4-[2-[(4-nitrophenyl)methoxycarbonylamino]acetyl]piperazine-1-carbonyl]-4-sulfanylpyrrolidine-1-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)NCC(=O)N1CCN(C(=O)[C@H]2N(C[C@@H](S)C2)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 HBTOGPHAEUNAJP-GOTSBHOMSA-N 0.000 description 1
- CIWHDHLPUVQSTP-DQEYMECFSA-N (4-nitrophenyl)methyl (2s,4s)-2-[4-[2-[2-[(4-nitrophenyl)methoxycarbonylamino]ethoxy]acetyl]piperazine-1-carbonyl]-4-sulfanylpyrrolidine-1-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)NCCOCC(=O)N1CCN(C(=O)[C@H]2N(C[C@@H](S)C2)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 CIWHDHLPUVQSTP-DQEYMECFSA-N 0.000 description 1
- HXDQKQGBOPTPKU-ZEQRLZLVSA-N (4-nitrophenyl)methyl (2s,4s)-2-[4-[2-[[2-[(4-nitrophenyl)methoxycarbonylamino]acetyl]amino]acetyl]piperazine-1-carbonyl]-4-sulfanylpyrrolidine-1-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)NCC(=O)NCC(=O)N1CCN(C(=O)[C@H]2N(C[C@@H](S)C2)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 HXDQKQGBOPTPKU-ZEQRLZLVSA-N 0.000 description 1
- NNIRBDBANIUFCX-OJSMNCEXSA-N (4-nitrophenyl)methyl (2s,4s)-2-[4-[2-amino-3-[(4-nitrophenyl)methoxy]-3-oxopropanoyl]piperazine-1-carbonyl]-4-sulfanylpyrrolidine-1-carboxylate Chemical compound C1CN(C(=O)[C@H]2N(C[C@@H](S)C2)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CCN1C(=O)C(N)C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 NNIRBDBANIUFCX-OJSMNCEXSA-N 0.000 description 1
- ZCTWEEUMJZVQIP-DQEYMECFSA-N (4-nitrophenyl)methyl (2s,4s)-2-[4-[4-[(4-nitrophenyl)methoxycarbonylamino]butanoyl]piperazine-1-carbonyl]-4-sulfanylpyrrolidine-1-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)NCCCC(=O)N1CCN(C(=O)[C@H]2N(C[C@@H](S)C2)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 ZCTWEEUMJZVQIP-DQEYMECFSA-N 0.000 description 1
- FDDCLWROXGDCFW-VMPREFPWSA-N (4-nitrophenyl)methyl (2s,4s)-4-benzoylsulfanyl-2-[4-[2-[(4-nitrophenyl)methoxycarbonylamino]acetyl]piperazine-1-carbonyl]pyrrolidine-1-carboxylate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)NCC(=O)N1CCN(C(=O)[C@H]2N(C[C@H](C2)SC(=O)C=2C=CC=CC=2)C(=O)OCC=2C=CC(=CC=2)[N+]([O-])=O)CC1 FDDCLWROXGDCFW-VMPREFPWSA-N 0.000 description 1
- LNAXHHZOSFTCPP-UHFFFAOYSA-N (4-nitrophenyl)methyl n-(4-oxo-4-piperazin-1-ylbutyl)carbamate Chemical compound C1=CC([N+](=O)[O-])=CC=C1COC(=O)NCCCC(=O)N1CCNCC1 LNAXHHZOSFTCPP-UHFFFAOYSA-N 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- DQXKOHDUMJLXKH-PHEQNACWSA-N (e)-n-[2-[2-[[(e)-oct-2-enoyl]amino]ethyldisulfanyl]ethyl]oct-2-enamide Chemical compound CCCCC\C=C\C(=O)NCCSSCCNC(=O)\C=C\CCCCC DQXKOHDUMJLXKH-PHEQNACWSA-N 0.000 description 1
- SBXLDJWHUKTQSY-IRXDYDNUSA-N 1-o-tert-butyl 2-o-ethyl (2s,4s)-4-[(4-methoxyphenyl)methylsulfanyl]pyrrolidine-1,2-dicarboxylate Chemical compound C1N(C(=O)OC(C)(C)C)[C@H](C(=O)OCC)C[C@@H]1SCC1=CC=C(OC)C=C1 SBXLDJWHUKTQSY-IRXDYDNUSA-N 0.000 description 1
- AECHWGVLQMAYEV-GJZGRUSLSA-N 1-o-tert-butyl 2-o-ethyl (2s,4s)-4-benzoylsulfanylpyrrolidine-1,2-dicarboxylate Chemical compound C1N(C(=O)OC(C)(C)C)[C@H](C(=O)OCC)C[C@@H]1SC(=O)C1=CC=CC=C1 AECHWGVLQMAYEV-GJZGRUSLSA-N 0.000 description 1
- XPECMNXMBZGWLP-UHFFFAOYSA-N 2-[(4-nitrophenyl)methoxycarbonylamino]acetic acid Chemical compound OC(=O)CNC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 XPECMNXMBZGWLP-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- VMNWGSPDNGKRMR-SFTDATJTSA-N 2-o-ethyl 1-o-[(4-nitrophenyl)methyl] (2s,4s)-4-[(4-methoxyphenyl)methylsulfanyl]pyrrolidine-1,2-dicarboxylate Chemical compound C([C@H](C[C@H]1C(=O)OCC)SCC=2C=CC(OC)=CC=2)N1C(=O)OCC1=CC=C([N+]([O-])=O)C=C1 VMNWGSPDNGKRMR-SFTDATJTSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- IVLICPVPXWEGCA-UHFFFAOYSA-N 3-quinuclidinol Chemical compound C1C[C@@H]2C(O)C[N@]1CC2 IVLICPVPXWEGCA-UHFFFAOYSA-N 0.000 description 1
- FTSYROLPLVUALL-UHFFFAOYSA-N 4-[(4-nitrophenyl)methoxycarbonylamino]butanoic acid Chemical compound OC(=O)CCCNC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 FTSYROLPLVUALL-UHFFFAOYSA-N 0.000 description 1
- VOLRSQPSJGXRNJ-UHFFFAOYSA-N 4-nitrobenzyl bromide Chemical compound [O-][N+](=O)C1=CC=C(CBr)C=C1 VOLRSQPSJGXRNJ-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- ZFXMMFDWDHIHGS-JJCDCTGGSA-N COC1=CC=C(C[S@@+](C[C@@H]2C([O-])=O)CN2C(OCC(C=C2)=CC=C2[N+]([O-])=O)=O)C=C1 Chemical compound COC1=CC=C(C[S@@+](C[C@@H]2C([O-])=O)CN2C(OCC(C=C2)=CC=C2[N+]([O-])=O)=O)C=C1 ZFXMMFDWDHIHGS-JJCDCTGGSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- LBWUXVCSHXPSRB-PBYQXAPXSA-N [N+](=O)([O-])C1=CC=C(COC(=O)N2[C@@H](C[S@@+](C2)CC2=CC=C(C=C2)OC)C(=O)Cl)C=C1 Chemical compound [N+](=O)([O-])C1=CC=C(COC(=O)N2[C@@H](C[S@@+](C2)CC2=CC=C(C=C2)OC)C(=O)Cl)C=C1 LBWUXVCSHXPSRB-PBYQXAPXSA-N 0.000 description 1
- 125000005042 acyloxymethyl group Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 150000003939 benzylamines Chemical class 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 108700003601 dimethylglycine Proteins 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- ANLRDBWTGZFMOC-KBPBESRZSA-N ethyl (2s,4s)-4-[(4-methoxyphenyl)methylsulfanyl]pyrrolidine-2-carboxylate Chemical compound C1N[C@H](C(=O)OCC)C[C@@H]1SCC1=CC=C(OC)C=C1 ANLRDBWTGZFMOC-KBPBESRZSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229940078490 n,n-dimethylglycine Drugs 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical class CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical compound C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 125000003808 silyl group Chemical class [H][Si]([H])([H])[*] 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14846991 | 1991-06-20 | ||
| JP3105492 | 1992-02-18 | ||
| PCT/JP1992/000790 WO1993000344A1 (en) | 1991-06-20 | 1992-06-19 | Carbapenem derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69232791D1 DE69232791D1 (en) | 2002-10-31 |
| DE69232791T2 true DE69232791T2 (de) | 2003-05-15 |
Family
ID=26369502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69232791T Expired - Fee Related DE69232791T2 (de) | 1991-06-20 | 1992-06-19 | Carbapenemderivate |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5559224A (https=) |
| EP (1) | EP0641795B9 (https=) |
| JP (1) | JP3048196B2 (https=) |
| KR (1) | KR100189667B1 (https=) |
| AT (1) | ATE224897T1 (https=) |
| AU (1) | AU659172B2 (https=) |
| CA (1) | CA2111974C (https=) |
| DE (1) | DE69232791T2 (https=) |
| DK (1) | DK0641795T3 (https=) |
| ES (1) | ES2184731T3 (https=) |
| FI (1) | FI101537B (https=) |
| NO (1) | NO303636B1 (https=) |
| RU (1) | RU2091381C1 (https=) |
| TW (1) | TW201747B (https=) |
| WO (1) | WO1993000344A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2026424A6 (es) * | 1991-02-26 | 1992-04-16 | Play Sa | Cuna infantil plegable. |
| EP0882728B1 (en) * | 1995-12-21 | 2002-09-04 | Sankyo Company Limited | 1-methylcarbapenem derivatives |
| PL343728A1 (en) * | 1998-05-01 | 2001-09-10 | Kyoto Pharmaceutical Ind | Carbapenem derivatives, utilization thereof and intermediate compounds of the same |
| AU2001230550A1 (en) * | 2000-01-31 | 2001-08-14 | Sankyo Company Limited | 1-methylcarbapenem compounds |
| IN191798B (https=) | 2000-11-03 | 2004-01-03 | Ranbaxy Lab Ltd | |
| CN1511156A (zh) * | 2001-05-21 | 2004-07-07 | ����ҩƷ��ҵ��ʽ���� | 碳青霉烯化合物 |
| WO2003027067A2 (en) * | 2001-09-26 | 2003-04-03 | Merck & Co., Inc. | Process for making carbapenem compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1283906C (en) * | 1983-05-09 | 1991-05-07 | Makoto Sunagawa | .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF |
| JPS6019787A (ja) * | 1983-07-12 | 1985-01-31 | Sumitomo Chem Co Ltd | 新規なβ−ラクタム化合物及びその製造法 |
| JPS60233076A (ja) * | 1984-05-03 | 1985-11-19 | Sumitomo Chem Co Ltd | 新規なβ−ラクタム化合物およびその製造法 |
| KR880006244A (ko) * | 1986-11-24 | 1988-07-22 | 후지사와 도모 기찌 로 | 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법 |
| AU631671B2 (en) * | 1989-08-04 | 1992-12-03 | Banyu Pharmaceutical Co., Ltd. | 2-(2-vinylpyrrolidinylthio)carbapenem derivatives |
-
1992
- 1992-06-18 JP JP04159017A patent/JP3048196B2/ja not_active Expired - Fee Related
- 1992-06-19 CA CA002111974A patent/CA2111974C/en not_active Expired - Fee Related
- 1992-06-19 TW TW081104823A patent/TW201747B/zh active
- 1992-06-19 RU RU93058465/04A patent/RU2091381C1/ru not_active IP Right Cessation
- 1992-06-19 AT AT92913257T patent/ATE224897T1/de not_active IP Right Cessation
- 1992-06-19 EP EP92913257A patent/EP0641795B9/en not_active Expired - Lifetime
- 1992-06-19 DE DE69232791T patent/DE69232791T2/de not_active Expired - Fee Related
- 1992-06-19 DK DK92913257T patent/DK0641795T3/da active
- 1992-06-19 AU AU20002/92A patent/AU659172B2/en not_active Ceased
- 1992-06-19 KR KR1019930703980A patent/KR100189667B1/ko not_active Expired - Fee Related
- 1992-06-19 ES ES92913257T patent/ES2184731T3/es not_active Expired - Lifetime
- 1992-06-19 WO PCT/JP1992/000790 patent/WO1993000344A1/ja not_active Ceased
-
1993
- 1993-12-17 NO NO934670A patent/NO303636B1/no unknown
- 1993-12-17 FI FI935698A patent/FI101537B/fi active
-
1995
- 1995-05-05 US US08/435,271 patent/US5559224A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK0641795T3 (da) | 2003-01-20 |
| AU659172B2 (en) | 1995-05-11 |
| AU2000292A (en) | 1993-01-25 |
| ATE224897T1 (de) | 2002-10-15 |
| KR940701395A (ko) | 1994-05-28 |
| NO934670L (no) | 1994-02-18 |
| RU2091381C1 (ru) | 1997-09-27 |
| ES2184731T3 (es) | 2003-04-16 |
| FI935698A0 (fi) | 1993-12-17 |
| CA2111974A1 (en) | 1993-01-07 |
| EP0641795B9 (en) | 2003-01-29 |
| CA2111974C (en) | 2001-07-24 |
| WO1993000344A1 (en) | 1993-01-07 |
| KR100189667B1 (ko) | 1999-06-01 |
| EP0641795A1 (en) | 1995-03-08 |
| FI935698A7 (fi) | 1994-02-04 |
| FI101537B1 (fi) | 1998-07-15 |
| NO303636B1 (no) | 1998-08-10 |
| TW201747B (https=) | 1993-03-11 |
| JP3048196B2 (ja) | 2000-06-05 |
| EP0641795A4 (en) | 1994-06-09 |
| US5559224A (en) | 1996-09-24 |
| FI101537B (fi) | 1998-07-15 |
| JPH05294969A (ja) | 1993-11-09 |
| EP0641795B1 (en) | 2002-09-25 |
| NO934670D0 (no) | 1993-12-17 |
| DE69232791D1 (en) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3780344T2 (de) | Beta-lactam-verbindungen und deren herstellung. | |
| DE68925223T2 (de) | 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen | |
| DE3785163T2 (de) | 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-en-2-carbonsaeurederivate und verfahren zu deren herstellung. | |
| DE3587126T2 (de) | Carbapenem-Derivate und sie enthaltende Zusammensetzung. | |
| DE68916071T2 (de) | 3-Pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en-2-carbonsäure-Verbindungen. | |
| DE3781980T2 (de) | Carbapenem-verbindung in kristalliner form und ihre herstellung und verwendung. | |
| DE69231834T2 (de) | Pyrrolidylthiocarbapenemderivat mit antibakterieller Wirkung | |
| DE69020676T2 (de) | Tricyclische Carbapenemverbindungen. | |
| DE69221003T2 (de) | Antibiotische Carbapenemderivate | |
| DE69129175T2 (de) | 1-Methylcarbapenemderivate und Verfahren zu ihrer Herstellung | |
| CH657853A5 (de) | Carbapenemderivate, deren herstellung und solche verbindungen enthaltende praeparate. | |
| AU662972B2 (en) | Carbapenem derivatives as antibiotics and intermediates thereof | |
| DE69121259T2 (de) | Beta-Lactam-Verbindungen und ihre Herstellung | |
| DE69232791T2 (de) | Carbapenemderivate | |
| CA1283659C (en) | Carbapenem antibiotics | |
| DE69732635T2 (de) | Cis-substituierte aminocyclopropanderivate | |
| DE69307355T2 (de) | Verfahren zur Herstellung von Sulfamid | |
| DE68916908T2 (de) | Carbapenemderivate. | |
| DE69120572T2 (de) | Carbapenem-Derivate, in 2-Stellung substituiert mit substituierten Pyrrolidinylthio-Gruppen | |
| DE69218843T2 (de) | Aminooxypyrrolidinylthiocarbapenem-Verbindungen | |
| DE60130916T2 (de) | Neue beta-lactamverbindungen und verfahren zu deren herstellung | |
| DE69523058T2 (de) | Carbapenem-derivate | |
| EP0235823B1 (en) | Carbapenem antibiotics, a process for preparing them and pharmaceutical compositions containing them | |
| DE69226951T2 (de) | Antibiotische carbapenemderivate | |
| DE69231375T2 (de) | Aminoalkylpyrrolidinylthiocarbapenemderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |